Tenders/Procurement of Drugs used in Respiratory System (Annual Requirements)MHPQ/PHARM/2026-2027/Q56 OIB

Procurement of Drugs used in Respiratory System (Annual Requirements)MHPQ/PHARM/2026-2027/Q56 OIB

HEALTH

Published: Sep 9, 2026

Updated: Sep 26, 2026

About This Opportunity

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Mauritius, Africa, this opportunity is open to firms and consortiums.

Published through Mauritius e-Procurement, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender relates to the procurement of drugs used in the respiratory system, covering annual requirements in Mauritius. The tender reference is MHPQ/PHARM/2026-2027/Q56 OIB. The contracting authority is expected to be a public health institution, likely within the Ministry of Health, responsible for the national pharmaceutical supply. This procurement seeks to ensure an adequate stock of medications essential for treating respiratory conditions. Typical requirements for bidders include the supply of specified respiratory drugs that meet international quality standards, such as GMP. Suppliers must demonstrate robust logistical capabilities to ensure consistent and timely delivery to designated health facilities. Eligibility usually extends to licensed pharmaceutical manufacturers or their authorized representatives with demonstrable experience in supplying government health programs. Evaluation will likely consider factors such as drug quality, therapeutic efficacy, pricing, supplier reliability, and adherence to Mauritian pharmaceutical regulations. Prospective bidders must review the complete tender documentation for precise details on the list of drugs, quantities, technical specifications, delivery terms, and the submission process. This procurement is critical for public health management.

Data provenance

This notice is sourced from Mauritius e-Procurement and was originally published on September 9, 2026. Last refreshed today. Reference: 776448. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About HEALTH

HEALTH has issued 260 procurement notices on BidsFactory, including 48 currently open and 20 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. Tenders span 3 countries including Mauritius, Canada, and South Africa. Notices are distributed via Mauritius e-Procurement, eTenders South Africa, and SaskTenders. Most recent publication: September 18, 2026.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by HEALTH in Mauritius. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Mauritius. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Mauritius e-Procurement to access the full notice, required documents, and submission instructions. Quote reference 776448 when communicating with the contracting authority.